bioRxivImmunologyPreprint
Establishment of pan-Influenza A (H1-H18) and pan-Influenza B (pre-split, Vic/Yam) Pseudotype Libraries for efficient vaccine antigen selection
J. M. Del Rosario, K. da Costa, B. Asbach, F. Ferrara, M. Ferrari, D. Wells, G. S. Mann, V. O. Ameh, C. T. Sabeta, A. C. Banyard, R. Kinsley, S. D. Scott, R. Wagner, J. L. Heeney, G. W. Carnell, N. J. Temperton
Abstract
We have developed an influenza hemagglutinin (HA) pseudotype library encompassing Influenza A subtypes HA1-18, and Influenza B subtypes (both lineages) to be employed in influenza pseudotype microneutralization (pMN) assays. The pMN is highly sensitive and specific for detecting virus-specific neutralizing antibodies against influenza viruses and can be used to assess antibody functionality in vitro. Here we show the production of these viral HA pseudotypes and their employment as substitutes for wildtype viruses in influenza serological and neutralization assays. We demonstrate its utility in detecting serum response to vaccination with the ability to evaluate cross-subtype neutralizing responses elicited by specific vaccinating antigens. Our findings may inform further pre-clinical studies involving immunization dosing regimens in mice and may help in the creation and selection of better antigens for vaccine design. These HA pseudotypes can be harnessed to meet strategic objectives that contribute to the strengthening of global influenza surveillance, expansion of seasonal influenza prevention and control policies, and strengthening pandemic preparedness and response.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Influenza A (N1-N9) and Influenza B (B/Vic and B/Yam) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine design
K. A. S. da Costa, J. M. M. Del Rosario, … N. J. Temperton·bioRxiv·Sep 19, 2021
- Development and use of Lentiviral Vectors Pseudotyped with Influenza B Haemagglutinins: application to vaccine immunogenicity, mAb potency and sero-surveillance studies
F. Ferrara, G. Carnell, … N. J. Temperton·bioRxiv·Dec 10, 2018
- Development of hybrid alphavirus-influenza A, B, and D pseudovirions for rapid quantification of neutralization antibodies and antiviral drugs
Brian Hetrick, Dongyang Yu, … Yuntao Wu·bioRxiv·Mar 4, 2026
- The use of hyperimmune chicken reference sera is not appropriate for the validation of influenza pseudotype neutralization assays
F. Ferrara, E. Molesti, … N. J. Temperton·bioRxiv·Aug 23, 2017
- The study of antibody responses to influenza neuraminidase using a lentiviral pseudotype based ELLA
Fabrizio Biuso, George Carnell, … Nigel Temperton·bioRxiv·Nov 13, 2017
- Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines
S. Boyoglu-Barnum, D. Ellis, … M. Kanekiyo·bioRxiv·May 30, 2020